NCT00237354View on ClinicalTrials.gov

PV-10 Chemoablation of Recurrent Breast Carcinoma

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

July 31, 2008

Conditions
Breast Cancer
Interventions
DRUG

PV-10 (rose bengal disodium 10%)

PV-10 ablation of study lesion

Trial Locations (1)

Unknown

Canterbury BreastCare, Christchurch

Sponsors
All Listed Sponsors
lead

Provectus Pharmaceuticals

INDUSTRY